Global hematology instruments and reagents market is projected to reach US$4.5 billion by 2010. Over the years hematology instruments have evolved from simple manual red blood cell counters to sophisticated automated analyzers. Capital replacement cycle controls the market, while aging population, automation drives, and detection of new diseases and conditions remain the primary factors buoying market growth.

San Jose, California (PRWEB) July 16, 2007 -- The hematology instruments and reagents market clearly belongs to specialized players. Competition in the market is centered on several factors including price, product innovation, service, distribution, and promotion strategies. Hence, the scenario essentially calls for significant investment in research and product innovation and strategic alliances to maintain competitive advantage.

The United States remains the leader in terms of market size with an estimated 38% share for 2007. Asia-Pacific is all set to be the fastest growing market for hematology/coagulation instruments and reagents. The market is projected to reach US$460 million by 2010. In Europe, the second largest market, Germany represents the leading market with sales estimated atUS$302 million for 2007.

Market for hematology and coagulation instruments is estimated at US$1.13 billion for 2007. Among the various sub segments analyzed under the category, hematology analyzers market is the largest, with a projected market size of US$512 million by 2010. Hematology flow cytometers market represent the fastest growing at a CAGR of 3.8%. Due to advancement in technology, flow cytometry devices are now modular and easy to operate. Opportunities exist in developing countries where cytometry and image analysis are still emerging.

In the hematology/coagulation reagents category, hematology reagents represent the dominant sub segment. Global hematology reagents market is projected to reach US$1.2 billion by 2010.

Demand for hematology analyzers is influenced by the development of alternative technologies such as POC instruments, and integrated analyzers, advancements in product automation, and highly streamlined lab processes. Near patient testing, blood thinning therapeutics and clot busting continue to remain the market drivers for coagulation analyzers market in near future. There exists strong demand for high throughput and specialty coagulation analyzers. More number of patients are moving towards home monitoring devices, which has led to a decline in demand for stand-alone coagulation analyzers. Low volume analyzers continue to be replaced by home monitoring devices.

Dominant forces in the global hematology instruments market include Beckman Coulter, Inc., Sysmex Corp. Abbott Diagnostics, Siemens Medical Solutions Diagnostics, and Horiba Group. Dade Behring, Beckman Coulter, Roche, and BioMerieux largely hold the coagulation analyzers market. Beckman Coulter, Sysmex, and Abbott together command 80% of the hematology instruments market in the US. Sysmex commands a strong presence in the Japanese market.

The report titled "Hematology Instruments and Reagents: A Global Strategic Business Report" unravels major trends and factors influencing the industry. The study highlights key factors influencing purchase decisions of clinical labs, replacement demand for hematology instruments, and ongoing innovations by manufacturers to develop systems for high volume laboratories. A theoretical backdrop of hematology, blood collection and processing techniques is provided to gain a better perspective. The report also offers detailed company profiles and enumerates recent developments, mergers, acquisitions and other strategic industry activities.

For more details of this research report please visit www.strategyr.com/MCP-3520.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site www.StrategyR.com

###

Simillar Articles

Global Immunoassay Instruments Market to Exceed $7.1 Billion by 2010, According to New Report by...

Global immunoassay instruments market is projected to cross $7.1 billion by 2010. Ageing population and technological advancements in healthcare industry is steadily expanding immunodiagnostics...

Blood Processing Supplies and Equipment Demand to exceed $7.6 billion in 2010, According to New...

Global blood processing supplies and equipment market is projected to exceed US$7.6 billion in 2010. Graying population and increase in surgical procedures represent the key drivers for the market.

World Blood Gas and Electrolyte Analyzers Market to Reach US$284.68 Million by 2010, According to...

Driven by the aging world population, and the rise in critical care treatments, and surgeries, the world market for blood gas and electrolyte analyzers is projected to reach US$284.68 million by...

Global Industry Analysts' Releases a Series of Medical Market Research Reports

GIA, a premier research company in San Jose, releases several research projects in the medical space. Each report provides a comprehensive insight into the product's current market scenario,...

Free Quick Start Guide (Clinical Laboratory) by Medical Sales Recruiter: Understand Role of...

Peggy McKee, owner and recruiter at PHC Consulting - search firm focused on medical laboratory sales, sales management and marketing talent, has just provided her "Quick Start Guide to the Clinical...

Home